Bonifacius A, Tischer Zimmermann S, Dragon A, Gussarow D, Vogel A, Krettek U, et al. COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses. Immunity. 2021;54:340-354.e6 pubmed publisher

Akhand S, Chen H, Purdy S, Liu Z, Anderson J, Willey C, et al. Fibroblast growth factor receptor facilitates recurrence of minimal residual disease following trastuzumab emtansine therapy. NPJ Breast Cancer. 2021;7:5 pubmed publisher

Hao M, Yeo S, Turner K, Harold A, Yang Y, Zhang X, et al. Autophagy Blockade Limits HER2+ Breast Cancer Tumorigenesis by Perturbing HER2 Trafficking and Promoting Release Via Small Extracellular Vesicles. Dev Cell. 2021;56:341-355.e5 pubmed publisher

Abu Tayeh H, Weidenfeld K, Zhilin Roth A, Schif Zuck S, Thaler S, Cotarelo C, et al. 'Normalizing' the malignant phenotype of luminal breast cancer cells via alpha(v)beta(3)-integrin. Cell Death Dis. 2016;7:e2491 pubmed publisher